Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy

New England Journal of Medicine

Volumn 341, Issue 27, 1999, Pages 2033-2038

  Walton, David L ^a   Norem, Carol T ^a   Schoen, Edgar J ^a   Ray, G Thomas ^b   Colby, Christopher J ^b  

^a KAISER PERMANENTE   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ETHNOLOGY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PLACENTA DISORDER; PREDICTION; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; STILLBIRTH;

ADOLESCENT; ADULT; CHORIONIC GONADOTROPIN; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; FETAL DEATH; HUMANS; OBSTETRIC LABOR, PREMATURE; ODDS RATIO; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033619939     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199912303412701     Document Type: Article

References (22)

1. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992;80:83-6.
2. Sorensen TK, Williams MA, Zingheim RW, Clement SJ, Hickok DE. Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol 1993;169:834-8.
3. Önderoǧlu L, Kabukçu A. Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome. Int J Gynaecol Obstet 1997;56:245-9.
4. Tanaka M, Natori M, Kohno H, Ishimoto H, Kobayashi T, Nozawa S. Fetal growth in patients with elevated maternal serum hCG levels. Obstet Gynecol 1993;81:341-3.
5. Benn PA, Horne D, Briganti S, Rodis JF, Clive JM. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol 1996;87:217-22.
6. Gravett CP, Buckmaster JG, Watson PT, Gravett MG. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome. Am J Med Genet 1992;44:485-6.
7. Heinonen S, Ryynänen M, Kirkinen P, Saarikoski S. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion. Am J Perinatol 1996;13:437-41.
8. Ashour AMN, Lieberman ES, Wilkins Haug LE, Repke JT. The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia. Am J Obstet Gynecol 1997;176:438-42.
9. Morssink LP, Kornman LH, Beekhuis JR, De Wolf BT, Mantingh A. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to weight and preterm delivery. Prenat Diagn 1995;15:1041-6.
10. The international classification of diseases, 9th rev., clinical modification: ICD-9-CM. Salt Lake City: Medicode, 1997.
11. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;82:703-10.
12. Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. Fetal growth and neonatal viability in California. Obstet Gynecol 1982;59:624-32.
13. Wilkins-Haug L. Unexplained elevated maternal serum alpha-fetoprotein: what is the appropriate follow-up? Curr Opin Obstet Gynecol 1998; 10:469-74.
14. Chalmers I, Enkin M, Keirse MJNC, eds. Effective care in pregnancy and childbirth. Oxford, England: Oxford University Press, 1989.
15. Gant NF, Cunningham FG. Management of preeclampsia. Semin Perinatol 1994;18:94-102.
16. Vasilenko P, Jorgensen KM. Incidence and impact of tobacco, alcohol, and cocaine during pregnancy. Presented at the 43rd ACOG Annual Meeting, San Francisco, May 8-11, 1995. abstract.
17. Glantz JC, Woods JR Jr. Cocaine, heroin, and phencyclidine: obstetric perspectives. Clin Obstet Gynecol 1993;36:279-301.
18. Vorherr H. Placental insufficiency in relation to postterm pregnancy and fetal postmaturity: evaluation of fetoplacental function: management of the postterm gravida. Am J Obstet Gynecol 1975;123:67-103.
19. Freeman RK, Anderson G, Dorchester M. A prospective multi-institutional study of antepartum fetal heart rate monitoring. I. Risk of perinatal mortality and morbidity according to antepartum fetal heart rate test results. Am J Obstet Gynecol 1982;143:771-7.
20. Abuelo DN, Hopmann MR, Barsel-Bowers G, Goldstein A. Anxiety in women with low maternal serum alpha-fetoprotein screening results. Prenat Diagn 1991;11:381-5.
21. Marteau TM, Cook R, Kidd J, et al. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn 1992;12:205-14.
22. Bodegård G, Fyrö K, Larsson A. Psychological reactions in 102 families with a newborn who has a falsely positive screening test for congenital hypothyroidism. Acta Paediatr Scand Suppl 1983;304:1-21.